Status:
COMPLETED
Biofreeze and the Effect on Knee Osteoarthritis
Lead Sponsor:
Memorial University of Newfoundland
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
50-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Knee osteoarthritis (OA) is a progressive disease that can be accompanied by considerable joint pain and dysfunction. It is a goal in the medical field to find effective treatments for knee OA that ar...
Detailed Description
Knee osteoarthritis (OA) is a disease which results in deterioration with articular cartilage and bone tissue of the knee joint (Felson et al., 2000). The disease is prevalent in the elderly and as it...
Eligibility Criteria
Inclusion
- Men and women aged 50-80 years
- Body mass index (BMI) less than 40
- Knee osteoarthritis of grade one or more according to Kellgren-Lawrence scale
- Average pain intensity of grade 4 or more on a 10-point visual analogue scale for at least 6 months.
- Meet clinical and radiographic criteria of the American College of Rheumatology (ACR) for knee OA
Exclusion
- Acute arthritis,
- Rheumatologic diseases
- Infective arthritis
- Traumatic arthritis,
- History of knee replacement surgery
- Patients receiving multiple corticosteroid injections (Greater than 2 injections)
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04351594
Start Date
November 1 2020
End Date
January 1 2024
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial University, Faculty of Medicine Department of Surgery
St. John's, Newfoundland and Labrador, Canada, A1B3V6